Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
suvorexant (SUVO)
Placebo
Locations
1
United States
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Start Date
March 9, 2023
Primary Completion Date
March 28, 2024
Completion Date
March 28, 2024
Last Updated
April 29, 2025
NCT06899594
NCT07086014
NCT06532370
NCT05322954
NCT07221396
NCT07399431
Lead Sponsor
The University of Texas Health Science Center, Houston
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions